Understanding how the host's ubiquitin system affects the replication of SARS-CoV-2.
The Role of the Host Ubiquitin System in Promoting SARS-CoV-2 replication and Pathogenesis
This study is looking at how a part of our body's system helps the COVID-19 virus grow and spread, with the hope that understanding this could lead to new treatments to fight the virus.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rutgers Biomedical and Health Sciences NIH-funded |
| Lab location | 1 site (Newark, UNITED STATES) |
| Project ID | NIH-10911100 on NIH RePORTER |
What this research studies
This research investigates the role of the host ubiquitin system in the replication and pathogenesis of SARS-CoV-2, the virus responsible for COVID-19. By examining how this system influences the virus's ability to enter and replicate within human cells, the study aims to uncover the molecular mechanisms that allow the virus to spread more efficiently and evade the immune response. The research employs advanced biochemical assays and bioinformatics to analyze the interactions between the virus and host cellular mechanisms. Ultimately, the findings could lead to the development of targeted antiviral therapies that disrupt these processes.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals affected by COVID-19, especially those with severe symptoms or complications.
Not a fit: Patients who have not been infected with SARS-CoV-2 or those with mild, asymptomatic cases may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to new antiviral treatments that effectively combat COVID-19 and its variants.
How similar studies have performed: Other research has shown promise in understanding viral mechanisms and developing antiviral strategies, indicating that this approach could yield significant insights.
Where this research is happening
Newark, UNITED STATES
- Rutgers Biomedical and Health Sciences — Newark, United States (Active)
Researchers
- Principal investigator: Rajsbaum, Ricardo — Rutgers Biomedical and Health Sciences
- Study coordinator: Rajsbaum, Ricardo
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.